Literature DB >> 30195837

Newborn screening for congenital heart disease using echocardiography and follow-up at high altitude in China.

Jing-Jing Li1, Yuan Liu2, Si-Yuan Xie1, Guo-Dong Zhao2, Ting Dai2, Hong Chen2, Lan-Fang Mu3, Hai-Ying Qi4, Jia Li5.   

Abstract

BACKGROUND: Pulse oximetry screening for critical congenital heart disease (CHD) is inapplicable to high altitude due to the variedly decreased arterial saturations and rare complex CHD. We examined the incidence and spectrum of CHD in newborns using echocardiography at high altitude and followed up their outcomes.
METHODS: A total of 1337 babies were studied. Echocardiography was performed in 1002 asymptomatic newborns (3-5 days). In the same period, retrospectively studied 394 newborns (≤2 days) admitted to the NICU where echocardiograph was performed in 335. In both groups, follow-up was made at 1-3, 6 and 12-18 months.
RESULTS: The incidence of CHD in asymptomatic newborns was 27.8%, consisting secundum atrial septal defect (ASD) [175 (62.7%)], patent ductus arteriosus (PDA) [61 (21.9%)], ventricular septal defect (VSD) [8 (2.9%)] and multiple defects [35 (12.6%)]. And 19.4% in NICU patients with similar spectrum, except for 2 with complex CHD who died before discharge. By 12-18 months of follow-up, 30% of CHD remained open. Thirteen patients developed mild to severe pulmonary arterial hypertension (PAH), and 2 of them died of heart failure.
CONCLUSIONS: The incidence of CHD in newborns at high altitude is about 20 times higher than that at low altitude, consisting mostly of simple forms with left to right shunt, with rare complex CHD. By 12-18 months, the incidence of CHD is still about 10 times higher than that at low altitude. About 8% patients developed PAH or death. Follow-up must be reinforced in order to provide early intervention and prevent from PAH or death.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Echocardiography screening; High altitude; Incidence of congenital heart defect; Newborns

Mesh:

Year:  2018        PMID: 30195837     DOI: 10.1016/j.ijcard.2018.08.102

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  4 in total

1.  Epidemiology of Congenital Heart Disease in Jinan, China From 2005 to 2020: A Time Trend Analysis.

Authors:  Lihua Zhang; Bei Liu; Huimin Li; Chengxiang Wang; Shimin Yang; Zhongliang Li
Journal:  Front Cardiovasc Med       Date:  2022-04-27

2.  Single-center experience with routine clinical use of 3D technologies in surgical planning for pediatric patients with complex congenital heart disease.

Authors:  Okan Yıldız; Banu Köse; I Cansaran Tanıdır; Kerem Pekkan; Alper Güzeltaş; Sertaç Haydin
Journal:  Diagn Interv Radiol       Date:  2021-07       Impact factor: 2.630

Review 3.  Pulmonary Hypertension in Acute and Chronic High Altitude Maladaptation Disorders.

Authors:  Akylbek Sydykov; Argen Mamazhakypov; Abdirashit Maripov; Djuro Kosanovic; Norbert Weissmann; Hossein Ardeschir Ghofrani; Akpay Sh Sarybaev; Ralph Theo Schermuly
Journal:  Int J Environ Res Public Health       Date:  2021-02-10       Impact factor: 3.390

4.  A Functional Variant Rs492554 Associated With Congenital Heart Defects Modulates SESN2 Expression Through POU2F1.

Authors:  Wenke Yang; Yi Li; Jun Bai; Tao You; Kang Yi; Dingxiong Xie; Xiaowei Zhang; Xiaodong Xie
Journal:  Front Cell Dev Biol       Date:  2021-06-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.